With a market cap of $194.5 billion, PepsiCo, Inc. (PEP) is a global food and beverage company offering snacks, cereals, beverages, and dairy products under brands like Pepsi, Lay’s, and Quaker. It operates in North America, Latin America, Europe, Africa, the Middle East, South Asia, and the Asia Pacific. The Purchase, New York-based company is scheduled to deliver its fiscal Q4 2025 results soon. Ahead of this event, analysts forecast PepsiCo to post an adjusted EPS of $2.24, up 14.3% from $1.96 in the ...

With a market cap of $294.2 billion, UnitedHealth Group Incorporated (UNH) is a diversified health care company operating in the United States and internationally through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The company provides health benefits, care delivery, data-driven health services, and pharmacy care solutions to individuals, employers, governments, and health care organizations. The largest U.S. health insurer is set to deliver its fiscal Q4 2025 results befo ...

Improved profitability driven by consecutive quarters of gross margin expansion and SG&A leverage Inventories down 17% vs. last year with net liquidity of $88.6 million Affirming the higher end of previously issued fiscal 2025 Adjusted EBITDA guidance range MOUNT HOREB, Wisc., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel and accessories, to ...

Core Insights - Kinder Morgan (KMI) has provided a 2026 forecast indicating a 4% increase in adjusted EBITDA to $8.7 billion and an adjusted EPS of $1.37, reflecting an approximate 8% growth from previous guidance [1][8] - The company plans to increase its annualized dividend for the ninth consecutive year to $1.19 per share while maintaining a net debt to adjusted EBITDA leverage ratio around 3.8, at the lower end of its long-term target band of 3.5–4.5 [2] Financial Projections - For 2026, Kinder Morgan plans $3.4 billion in discretionary capital expenditure, which will be funded through internally generated cash flows, supporting its stable business model as a leading transporter of natural gas [3][8] - The long-term take-or-pay contracts for KMI's pipeline and storage assets ensure a consistent revenue stream, providing stability against fluctuations in natural gas volumes [4][8] Industry Context - Other midstream players such as The Williams Companies, Inc. (WMB), Enterprise Products Partners L.P. (EPD), and MPLX LP (MPLX) also exhibit stable fee-based revenues and are less vulnerable to oil and gas price volatility, each currently holding a Zacks Rank 3 [5] - WMB is planning to invest $3.95 billion to $4.25 billion in capital expenditure by 2025, significantly higher than its $1.5 billion expenditure in 2024 [6] - MPLX returned a total of $1.1 billion to its unit holders in the third quarter of 2025, demonstrating a strong focus on returning capital through distributions and unit repurchases [7]

Core Insights - Willis Towers Watson (WTW) has a market capitalization of $30.2 billion and operates in two segments: Health, Wealth & Career, and Risk & Broking, providing integrated services globally [1] Performance Overview - WTW shares have underperformed compared to the broader market over the past 52 weeks, with a marginal increase in stock price while the S&P 500 Index has risen by 11% [2] - Year-to-date, WTW shares are up slightly, contrasting with the S&P 500's gain of 12.3% [2] - The company's stock has also lagged behind the Financial Select Sector SPDR Fund's nearly 3% return over the same period [3] Financial Results - In Q3 2025, WTW reported adjusted EPS of $3.07 and revenue of $2.29 billion, which was better than expected; however, shares fell marginally due to flat year-over-year revenue largely attributed to the sale of the TRANZACT business [4] - The loss of the TRANZACT business, which contributed $1.14 to adjusted EPS in 2024, and the anticipated net headwind of about $0.10 per share from a reinsurance joint venture with Bain Capital were significant factors affecting investor sentiment [4] - Analysts project a slight decline in adjusted EPS to $16.87 for the fiscal year ending December 2025, with a mixed earnings surprise history [5] Analyst Ratings and Price Targets - Among 23 analysts covering WTW, the consensus rating is a "Moderate Buy," with 12 "Strong Buy" ratings, one "Moderate Buy," nine "Holds," and one "Strong Sell" [5] - Barclays analyst Alex Scott has cut the price target on WTW to $303 and reiterated an "Underweight" rating, while the mean price target of $366.63 suggests a 16.4% premium to current price levels [6] - The highest price target of $400 indicates a potential upside of nearly 27% [6]

Core Insights - Bunge Global SA has a market capitalization of $18.2 billion and operates in four major segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy [1] Performance Overview - Over the past 52 weeks, Bunge's stock has increased by 3.7%, underperforming the S&P 500 Index, which gained 13.7%. However, year-to-date, Bunge's shares have risen by 20.9%, outperforming the S&P 500's 13.4% increase [2] - Bunge's shares have also outperformed the Consumer Staples Select Sector SPDR Fund, which saw a nearly 4% decline over the same period [3] Financial Results - On November 5, Bunge's Q3 2025 adjusted EPS was reported at $2.27, exceeding expectations. The acquisition of Viterra significantly boosted volumes, leading to a 67% increase in soy processing and refining profit, more than doubling softseed processing profit, and a 56% profit increase in grain merchandising and milling [4] - For the fiscal year ending December 2025, analysts project an 18.5% year-over-year decline in adjusted EPS to $7.49. Bunge has a mixed earnings surprise history, beating consensus estimates in three of the last four quarters [5] Analyst Ratings - Among nine analysts covering Bunge, the consensus rating is a "Strong Buy," with seven "Strong Buy" ratings and two "Holds" [5] - J.P. Morgan analyst Thomas Palmer maintained a "Buy" rating on Bunge and reaffirmed a price target of $109. The mean price target of $103.78 indicates a 10.4% premium to the current price, while the highest target of $120 suggests a potential upside of 27.7% [6]

Core Insights - Brady Corporation reported a 7.5% increase in sales for the first quarter of fiscal 2026, reaching $405.3 million compared to $377.1 million in the same quarter last year [2][4] - The company experienced a 16.5% increase in income before income taxes, amounting to $68.5 million, and a net income of $53.9 million, up from $46.8 million in the previous year [3][4] - Adjusted diluted earnings per share (EPS) rose by 8.0% to $1.21, reflecting strong organic sales growth and improved gross profit margins [5][6] Financial Performance - Sales increased by 7.5%, driven by a 2.8% organic sales growth, a 3.2% increase from acquisitions, and a 1.5% boost from foreign currency translation [2][6] - By region, sales in the Americas & Asia rose by 9.6%, while Europe & Australia saw a 3.6% increase, with organic sales growth of 4.7% in the Americas & Asia and a decline of 0.8% in Europe & Australia [2][20] - Net income for the quarter was $53.9 million, with diluted EPS increasing to $1.13 from $0.97 in the same quarter last year [4][6] Adjusted Financial Metrics - Adjusted income before income taxes was $73.8 million, a 7.6% increase compared to the previous year [3][26] - Adjusted net income reached $58.0 million, compared to $54.2 million in the same quarter last year [4][26] - The company raised its adjusted diluted EPS guidance for the fiscal year ending July 31, 2026, from a range of $4.85 to $5.15 per share to $4.90 to $5.15 per share [6][7] Strategic Developments - The acquisition of Mecco at the beginning of the quarter is expected to enhance Brady's laser marking system product line, complementing the previous acquisition of Gravotech [5] - The company maintains a net cash position of $66.8 million, allowing for continued strategic investments and shareholder returns through dividends and share buybacks [5][6] Cash Flow and Guidance - Cash flow from operating activities increased by 42.5% to $33.4 million compared to $23.4 million in the same quarter last year [6] - The fiscal 2026 guidance includes an estimated income tax rate of approximately 21%, depreciation and amortization expense of about $44 million, and capital expenditures of around $40 million [8]

Core Insights - CVS Health reported a strong third quarter with a 47% year-over-year increase in adjusted earnings per share (EPS) to $1.60 and record revenues of $103 billion, up approximately 8% from the previous year [1][8] - The company has raised its full-year 2025 adjusted EPS guidance for the third consecutive time, now projecting between $6.55 and $6.65, compared to the earlier range of $6.30-$6.40 [1] CVS Health Performance - The Health Care Benefits segment saw a significant turnaround with adjusted operating income of approximately $314 million, driven by the government business and the impact of the Inflation Reduction Act on the Medicare Part D program [2] - The medical benefit ratio improved to 92.8%, a decrease of 240 basis points year over year, indicating better cost management [2] - The Pharmacy & Consumer Wellness segment experienced nearly 12% revenue growth, attributed to an increase in prescription volume and the acquisition of Rite Aid's prescription files [3][8] Market Position and Valuation - CVS Health shares have increased by 43.5% over the past year, contrasting with a 5.5% decline in the industry [6] - The company is currently trading at a forward five-year price/sales (P/S) ratio of 0.23, which is lower than the industry average of 0.45 [9]

Core Insights - Fluor Corporation reported its financial results for Q3 2025, highlighting a commitment to disciplined project delivery and value creation for clients and shareholders [2][6]. Financial Performance - Revenue for Q3 2025 was $3.4 billion, down 18% year-over-year, primarily due to a $653 million reversal related to the Santos ruling [7]. - The company recorded a GAAP net loss of $697 million, which includes a $653 million charge for the Santos ruling and a $401 million reduction in NuScale's share price [7]. - Adjusted EBITDA was $161 million, reflecting a 29% increase year-over-year, while adjusted EPS was $0.68, up 33% year-over-year [7][22]. - General and administrative expenses increased by 16% year-over-year to $43 million, which included $12 million in restructuring costs [7]. Guidance and Outlook - The company revised its adjusted EBITDA guidance to $510 to $540 million and adjusted EPS guidance to $2.10 to $2.25 per share [5]. - Fluor's backlog stood at $28.2 billion, with 82% being reimbursable, down 10% year-over-year [6][21]. Segment Performance - Urban Solutions reported a profit of $61 million with revenue increasing to $2.3 billion, up from $1.9 billion a year ago [9]. - Energy Solutions experienced a loss of $533 million, with revenue decreasing to $262 million from $1.4 billion due to the Santos litigation [10]. - Mission Solutions reported a profit of $34 million, with revenue increasing to $761 million from $635 million a year ago [11]. Shareholder Returns - The company repurchased $70 million in shares during Q3 and is targeting an additional $800 million through February 2026 [6]. - Fluor announced a comprehensive agreement for the conversion and monetization of its remaining stake in NuScale, expecting full monetization by the end of Q2 2026 [2][6].

Financial Performance - Block's adjusted EPS missed estimates, coming in at $0.54 versus the expected $0.67 [1] - Revenue also missed estimates, reported as $61.1 billion versus the expected $63.1 billion [1] - Adjusted EBITDA was light at $833 million, compared to the street estimate of $840 million [2] Company Performance & Guidance - Block has reported a double miss for the fourth consecutive quarter [1] - Block has missed on revenue for the sixth straight quarter [1] - Gross profit is a bright spot, with back-to-back quarters of double-digit growth [2] - The company is now guiding to $102 billion in gross profit [2]